Melanocortin and dermal research
Melanotan II
Lyophilized dermal or melanocortin research peptide
Melanotan II is a melanocortin receptor research peptide connected to pigment, appetite, and central melanocortin-pathway literature.
Support can confirm any currently available COAs or batch documentation for this product.
Request available documentsConfirm an optional email signup to receive a single-use 10% welcome code.
Get catalog updatesAlleen voor laboratoriumonderzoek. Niet voor menselijk of diergeneeskundig gebruik. Niet bedoeld voor het diagnosticeren, behandelen, genezen, verzachten of voorkomen van ziekten.
Afgesloten, koud, droog en beschermd tegen hitteschommelingen bewaren. Bevestig productspecifieke opslag bij aankomst.
Verpakt voor stabiliteit tijdens het transport, met bestelondersteuning beschikbaar voor routes bij warm weer.
Batch-linked certificate support is available through the documentation desk.
Onderzoekscontext
Melanotan II onderzoeksprofiel
Melanotan II is a cyclic alpha-MSH analog studied across multiple melanocortin receptors, including MC1R and central MC3R or MC4R pathways. Research covers melanogenesis, receptor selectivity, cyclic-AMP signaling, appetite-related observations, and other central melanocortin responses. This broader receptor profile distinguishes it from Melanotan I, which is generally approached as a more pigment-centered reference, and from PT-141, which is studied primarily for central melanocortin signaling. Melanotan II is best selected for comparative receptor pharmacology where broad melanocortin activity is intentional. Early experimental findings do not establish safety or suitability for personal, cosmetic, or clinical use.
Voorgesteld mechanisme
A cyclic alpha-MSH analog with agonist activity across several melanocortin receptors, including MC1R and central MC3R/MC4R. This broader profile links pigment signaling with appetite, autonomic, and sexual-response pathways.
In studies gerapporteerde effecten
- Early human studies reported increased skin pigmentation and spontaneous erectile responses under experimental conditions.
- Animal studies report reduced food intake and changes in energy-balance and central melanocortin signaling.
- Nausea, flushing, yawning, appetite changes, and pigment or nevus changes have been reported or observed.
Veelgebruikte onderzoekseindpunten
MC1R, MC3R, and MC4R potency, cyclic AMP, melanin, skin reflectance, food intake, body mass, erectile response, blood pressure, heart rate, nausea, and pigment changes.
Bewijs en beperkingen
Preclinical and limited early human pharmacology exists, but there is no approved Melanotan II product and long-term safety is not established.
External reading
Literature for context—not product proof.
Third-party sources describe their own research materials and methods. They do not validate a specific Azure catalog batch.
Support and documentation
Questions about this product?
What documentation can I request before ordering?
Before ordering, contact support with the product name, selected format, andu2014if availableu2014an order or batch reference to request available batch-linked documentation.
What should I confirm before ordering?
Compare the product name, listed amount, physical form, storage note, price, and documentation route. When the order arrives, match the product and lot or batch reference to the order record and available documentation.